1. Double‐blind placebo‐controlled trial of the effect of omalizumab on basophils in chronic urticaria patients. Issue 2 (12th December 2017) Authors: Jörg, L.; Pecaric‐Petkovic, T.; Reichenbach, S.; Coslovsky, M.; Stalder, O.; Pichler, W.; Hausmann, O. Journal: Clinical & experimental allergy Issue: Volume 48:Issue 2(2018) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗